2021
Risk of chronic arthralgia and impact of pain on daily activities in a cohort of patients with chikungunya virus infection from Brazil
Silva M, Kikuti M, Anjos R, Portilho M, Santos V, Gonçalves T, Tauro L, Moreira P, Jacob-Nascimento L, Santana P, Campos G, Siqueira A, Kitron U, Reis M, Ribeiro G. Risk of chronic arthralgia and impact of pain on daily activities in a cohort of patients with chikungunya virus infection from Brazil. International Journal Of Infectious Diseases 2021, 105: 608-616. PMID: 33684559, DOI: 10.1016/j.ijid.2021.03.003.Peer-Reviewed Original ResearchConceptsChronic arthralgiaChikungunya virus infectionRisk factorsVirus infectionDaily activitiesAcute febrile illnessIndependent risk factorPersistence of painCohort of patientsImpact of painProgression of diseaseTranscriptase-polymerase chain reactionPersistent arthralgiaFebrile illnessSubstantial disabilityViral loadFemale sexPolymerase chain reactionIgM enzymeArthralgiaSurveillance studyChikungunya virusDengue virusPatientsImmunosorbent assay
2020
Changes in the dynamics of dengue incidence in South and Central America are possibly due to cross‐population immunity after Zika virus epidemics
Mugabe V, Borja L, Cardoso C, Weaver S, Reis M, Kitron U, Ribeiro G. Changes in the dynamics of dengue incidence in South and Central America are possibly due to cross‐population immunity after Zika virus epidemics. Tropical Medicine And International Health 2020, 26: 272-280. PMID: 33190402, DOI: 10.1111/tmi.13526.Peer-Reviewed Original ResearchConceptsDengue casesLaboratory-confirmed dengue casesDENV vaccine developmentSignificant public health implicationsDengue virus infectionDengue incidenceLong-term surveillance studyCross-species immunityPublic health implicationsIncidence of dengueVirus immunityVirus infectionEpidemiological dataSurveillance studyDengue feverZika virusDisease severityVaccine developmentIncidenceZika epidemicAnnual dengue incidenceZika outbreakHealth implicationsImmunityOverall rate
2019
Evaluation of two commercially available chikungunya virus IgM enzyme-linked immunoassays (ELISA) in a setting of concomitant transmission of chikungunya, dengue and Zika viruses
Kikuti M, Tauro L, Moreira P, Nascimento L, Portilho M, Soares G, Weaver S, Reis M, Kitron U, Ribeiro G. Evaluation of two commercially available chikungunya virus IgM enzyme-linked immunoassays (ELISA) in a setting of concomitant transmission of chikungunya, dengue and Zika viruses. International Journal Of Infectious Diseases 2019, 91: 38-43. PMID: 31704226, DOI: 10.1016/j.ijid.2019.11.001.Peer-Reviewed Original ResearchConceptsConvalescent samplesIgM enzymeRT-PCRZika virus transmissionNegative patientsCHIKV infectionAcute samplesZIKV casesConvalescent seraSurveillance studyCHIKV transmissionZika virusCHIKV casesDiagnostic performanceLow specificityVirus transmissionEquivocal resultsTest sensitivitySerumELISA specificityPatientsHigh rateDengueConcomitant transmissionMore equivocal results